News Highlights: Top Company News of the Day - Monday at 1 PM ET
January 08 2024 - 1:15PM
Dow Jones News
Novartis in Advanced Talks to Buy Cytokinetics
Novartis is close to clinching an acquisition of Cytokinetics
and its promising heart drug.
FAA Approves Inspection Method for Grounded 737 MAX 9 Jets
The agency has approved procedures for airlines to inspect their
grounded 737 MAX 9 jets, clearing the way for the planes to return
to service.
Tiger Woods and Nike Split Up After 27 Years
The 15-time major golf champion had one of the longest, and most
lucrative, endorsement deals in sports.
Apple's Vision Pro to Become Available In U.S. Feb. 2
Apple's new mixed-reality headset will become available in the
U.S. starting Feb. 2, setting the stage for the company's
premium-priced offering to compete in a crowded market.
Bank of America Recognizes $1.6 Billion Charge on Discontinuation of Loan Index
The charge was related to the discontinuation of an alternative
reference rate, the Bloomberg Short-Term Bank Yield Index.
Twilio's stock up more than 6% as CEO Jeff Lawson steps down
The surprise move comes as the enterprise-communications
software company battles two activist investors pushing for big
changes at Twilio.
Boston Scientific to Acquire Axonics For About $3.7 Billion
Axonics had agreed to be bought for $71 a share. Boston
Scientific said the deal gave Axonics an equity value of $3.7
billion and an enterprise value of $3.4 billion.
Johnson & Johnson to Acquire Ambrx for $2 Billion
Johnson & Johnson will acquire cancer-treatment developer
Ambrx Biopharma in a $2 billion cash deal.
Newell Brands to Cut 7% of Office Roles, Reduce Footprint
Newell Brands will slash about 7% of its office roles and pare
down its real-estate footprint in an organizational
realignment.
Merck to Buy Harpoon Therapeutics for $680 Million
Merck has struck a deal to buy clinical-stage immunotherapy
company Harpoon Therapeutics for about $680 million.
(END) Dow Jones Newswires
January 08, 2024 13:00 ET (18:00 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.